Clinical Trials

Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)

Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

A Study of OV101 in Individuals With Angelman Syndrome (AS)

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants

A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

A Trial of Levodopa in Angelman Syndrome

An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome

Angelman & Rett Syndrome: Interaction and Communication

Angelman Syndrome (AS) Biomarker Study

Angelman Syndrome Video Assessment (ASVA) Source Material Study

Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances

Characterization of Angelman Syndrome

Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome

Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA

Diagnosis of Prader-Willi Syndrome and Angelman Syndrome

Dietary Supplements for the Treatment of Angelman Syndrome